Found: 7
Select item for more details and to access through your institution.
Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42-PAK1 axis.
- Published in:
- Journal of Pathology, 2017, v. 243, n. 2, p. 208, doi. 10.1002/path.4940
- By:
- Publication type:
- Article
Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1077768
- By:
- Publication type:
- Article
An infection-induced RhoB-Beclin 1-Hsp90 complex enhances clearance of uropathogenic Escherichia coli.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22726-8
- By:
- Publication type:
- Article
Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC.
- Published in:
- FASEB Journal, 2020, v. 34, n. 6, p. 7927, doi. 10.1096/fj.201903266RR
- By:
- Publication type:
- Article
Expression, purification, and activity assay of peptide deformylase from Escherichia coli and Staphylococcus aureus.
- Published in:
- Molecular & Cellular Biochemistry, 2011, v. 357, n. 1/2, p. 47, doi. 10.1007/s11010-011-0874-6
- By:
- Publication type:
- Article
Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77450-y
- By:
- Publication type:
- Article
FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 2, p. 1, doi. 10.1038/s41419-017-0066-8
- By:
- Publication type:
- Article